ID 5 -
Witaminy i minerały
PL: Witaminy i minerały
EN: All vitamins and minerals
Pdf: vitamins, minerals
Oświadczenie (2)
- witamin i minerałów podczas ciąży i laktacji
- multiwitaminowa suplementacja by utrzymać żywotność podczas starzenia
- rozwój
1. Charakterystyka żywności / składnika
The food constituents that are the subject of the health claims are vitamins and minerals, and for IDs 7, 717 and 3094 also omega-3 fatty acids, all of which are well recognised nutrients. These nutrients are measurable in foods by established methods.
Vitamins and minerals are authorised for addition to foods and for use in food supplements (Annex I of Regulation (EC) No 1925/20066 and Annex I of Directive 2002/46/EC7). This evaluation applies to vitamins and minerals naturally present in foods and those forms authorised for addition to foods and for use in food supplements (Annex II of Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The main dietary omega-3 fatty acids are alpha-linolenic acid (ALA) and long-chain omega-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (EFSA, 2005).
The Panel considers that the food constituents, vitamins, minerals and omega-3 fatty acids, which are the subject of the health claims, are sufficiently characterised in relation to the claimed effects.
2.3. Dostarczanie witamin i minerałów podczas ciąży i karmienia piersią (ID 5)
For ID 5 the claimed effect is “vitamins and minerals during pregnancy and lactation”. In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the supply of vitamins and minerals to the body during pregnancy and lactation. The Panel considers that the claimed effect refers to the supply of a food constituent to the human body, rather than to a relationship between a food/food constituent and health as required by Regulation (EC) No 1924/2006.
For IDs 1, 2, 3, 7, 10, 11, 12, 111, 112, 168, 173, 174, 179, 184, 201, 210, 362, 372, 717, 1464, 1515, 2872, 2874, 3094, 3095, 4279, 4280, 4281, 4282, 4284, 4285, 4286, 4287, 4289, 4291, 4292 and 4708 the claimed effects refer to contribution to normal macronutrient and energy-yielding metabolism (ID 1, 184, 362, 4284, 4291, 4292), contribution to normal synthesis of nucleic acids (ID 1), contribution to normal collagen synthesis (ID 1), protection of DNA, proteins and lipids from oxidative damage (ID 1, 2872, 4285, 4286, 4287, 4289), contribution to normal conception and reproduction (ID 2, 3), normal tissue growth during pregnancy (ID 7, 717, 3094, 3095), contribution to the maintenance or achievement of a normal body weight (ID 12, 4708), contribution to normal homocysteine metabolism (ID 112), maintenance of normal vision (ID 168, 179, 201, 372, 1464), maintenance of normal bone (ID 111, 173, 210), maintenance of normal teeth (ID 173), maintenance of normal skin (ID 174), maintenance of normal hair (ID 174, 2874, 4282), maintenance of normal nails (ID 174, 2874, 4282), contribution to normal psychological functions (ID 10, 11, 1515, 4279, 4280, 4281), and reduction of tiredness and fatigue (ID 4279). The Panel considers that the target population is the general population.
Essential nutrients, including vitamins and minerals, are needed by the human body to maintain normal physiological functions. Individual vitamins, minerals and omega-3 fatty acids have various and different metabolic roles.
Claims on the role of individual vitamins and minerals (EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009a, 2009b, 2009c, 2009d, 2009e, 2009f, 2009g, 2009h, 2009i, 2009j, 2009k, 2009l, 2009m, 2009n, 2009o, 2009p, 2009q, 2009r, 2009s, 2009t, 2009u, 2010s, 2010w, 2010a, 2010b, 2010c, 2010d, 2010e, 2010f, 2010g, 2010h, 2010i, 2010j, 2010k, 2010l, 2010m, 2010n, 2010o, 2010p, 2010q, 2010r, 2010v, 2010t, 2010u, 2011b, 2011c, 2011a) and of omega-3 fatty acids (EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009v, 2009w, 2010x, 2010y, 2010z, 2011d, 2011e) on various body functions have already been evaluated in previous opinions.
Warunki i możliwe ograniczenia stosowania oświadczenia
only for multivitamins/ minerals with at least 400 µg folic acid
Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or [name of mineral/s]" as per Annex to Regulation 1924/2006.
'All vitamins and minerals' refers to a